Terry C. Davis, PhD; Michael S. Wolf, PhD, MPH; Pat F. Bass III, MD; Jason A. Thompson, BA; Hugh H. Tilson, MD, DrPH; Marolee Neuberger, MS; Ruth M. Parker, MD
Note: Drs. Davis and Wolf contributed equally to the creation of this manuscript.
Acknowledgments: The authors thank Jian Huang, MD, Robert Jackson, MD, Paul Cooper, MD, Jennifer Singh, MD, and Mark Middlebrooks, PharmD, for their aid in selecting the medication prescriptions. They also thank Connie Manning, Anna Bocchini, Stephanie Savory, and Silvia Skripkauskas for their help in data collection; Mickey Eder, PhD, and Molly Kaser for supporting recruitment efforts at the study locations; Ed Vonesh, PhD, and Fred Rademaker, PhD, for their guidance on statistical matters; and Mary Bocchini, Kat Davis, Jenney Palmer, and Courtney Noble, MD, for their assistance in coding patient responses.
Grant Support: Dr. Wolf is supported by a career development award through the Centers for Disease Control and Prevention (1 K01 EH000067-01).
Potential Financial Conflicts of Interest: Consultancies: H.H. Tilson (AstraZeneca, Abbott, Bristol-Myers Squibb, Gilead, Intermune, GlaxoSmithKline, Pfizer Inc., Eli Lilly Inc.); Honoraria: T.C. Davis (Pfizer Inc.), H.H. Tilson (Antiretrovirals in Pregnancy Registry, Centers for Education Research on Therapeutics, U.S. Food and Drug Administration); Stock ownership or options (other than mutual funds): T.C. Davis (Pfizer Inc., Johnson & Johnson), H.H. Tilson (GlaxoSmithKline, Gilead); Grants received: T.C. Davis (Pfizer Inc., Roche).
Requests for Single Reprints: Terry C. Davis, PhD, Department of Medicine–Pediatrics, Louisiana State University Health Science Center–Shreveport, 1501 Kings Highway, Shreveport, LA 71104; e-mail, TDAVIS1@lsuhsc.edu.
Current Author Addresses: Drs. Davis and Bass: Department of Medicine-Pediatrics, Louisiana State University Health Sciences Center-Shreveport, 1501 Kings Highway, Shreveport, LA 71130.
Dr. Wolf and Mr. Thompson: Health Literacy and Learning Program, Center for Health Care Studies, Northwestern University, Suite 200, 676 North St. Clair Street, Chicago, IL 60611.
Dr. Tilson: Public Health Leadership, University of North Carolina, School of Public Health, Public Health Leadership Program, Suite D-4a, 220 North Greensboro Street, Chapel Hill, NC 27510.
Ms. Neuberger: Western Michigan Area Health Education Center, 3443 Zion Road, Jackson, MI 49201.
Dr. Parker: Emory University School of Medicine, Faculty Office Building, 49 Jesse Hill Jr. Drive, NE, Atlanta, GA 30303.
Author Contributions: Conception and design: T.C. Davis, M.S. Wolf, P.F. Bass, M. Neuberger, R.M. Parker.
Analysis and interpretation of the data: T.C. Davis, M.S. Wolf, H.H. Tilson, R.M. Parker.
Drafting of the article: T.C. Davis, M.S. Wolf, P.F. Bass, H.H. Tilson.
Critical revision of the article for important intellectual content: T.C. Davis, M.S. Wolf, P.F. Bass, J.A. Thompson, H.H. Tilson, M. Neuberger, R.M. Parker.
Final approval of the article: T.C. Davis, M.S. Wolf, J.A. Thompson, H.H. Tilson, R.M. Parker.
Provision of study materials or patients: T.C. Davis, M.S. Wolf, R.M. Parker.
Statistical expertise: M.S. Wolf, J.A. Thompson.
Administrative, technical, or logistic support: M.S. Wolf.
Collection and assembly of data: M.S. Wolf, M. Neuberger, R.M. Parker.
Health literacy has increasingly been viewed as a patient safety issue and may contribute to medication errors.
To examine patients' abilities to understand and demonstrate instructions found on container labels of common prescription medications.
Cross-sectional study using in-person, structured interviews.
3 primary care clinics serving mostly indigent populations in Shreveport, Louisiana; Jackson, Michigan; and Chicago, Illinois.
395 English-speaking adults waiting to see their providers.
Correct understanding of instructions on 5 container labels; demonstration of 1 label's dosage instructions.
Correct understanding of the 5 labels ranged from 67.1% to 91.1%. Patients reading at or below the sixth-grade level (low literacy) were less able to understand all 5 label instructions. Although 70.7% of patients with low literacy correctly stated the instructions, “Take two tablets by mouth twice daily,” only 34.7% could demonstrate the number of pills to be taken daily. After potential confounding variables were controlled for, low (adjusted relative risk, 2.32 [95% CI, 1.26 to 4.28]) and marginal (adjusted relative risk, 1.94 [CI, 1.14 to 3.27]) literacy were significantly associated with misunderstanding. Taking a greater number of prescription medications was also statistically significantly associated with misunderstanding (adjusted relative risk, 2.98 [CI, 1.40 to 6.34] for ≥5 medications).
The study sample was at high risk for poor health literacy and outcomes. Most participants were women, and all spoke English. The authors did not examine the association between misunderstanding and medication error or evaluate patients' actual prescription drug-taking behaviors.
Lower literacy and a greater number of prescription medications were independently associated with misunderstanding the instructions on prescription medication labels.
Low literacy contributes to medical and drug nonadherence.
The authors tested patients in indigent communities to see how well they understood pill bottle labels. Patients with lower literacy levels and those taking a greater number of medications were less able to understand the meaning of the labels. Even among patients who understood the labels, only a minority could correctly demonstrate how to take the pills.
Patients' actual drug-taking behaviors were not observed, so the authors could not demonstrate a link between misunderstanding and medication errors.
Lower literacy and a greater number of medications being taken were associated with patient misunderstanding of pill bottle labels.
Table 1. Sample Characteristics Stratified by Literacy Level*
Table 2. Percentage of Patients Understanding Primary Prescription Drug Label Instructions and Attending to Auxiliary Labels* by Literacy Level
Table 3. Risk Factors for Misunderstanding Prescription Medication Label Instructions*
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
The prevalence of misunderstanding dosing based on drug labels among patients with adequate, marginal, and low literacy were from 38% to 62%.
Davis TC, Wolf MS, Bass PF, et al. Literacy and Misunderstanding Prescription Drug Labels. Ann Intern Med. 2006;145:887–894. doi: 10.7326/0003-4819-145-12-200612190-00144
Download citation file:
Published: Ann Intern Med. 2006;145(12):887-894.
Healthcare Delivery and Policy, Hospital Medicine, Prevention/Screening.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use